BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25110966)

  • 1. Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.
    Pascual JM; Liu P; Mao D; Kelly DI; Hernandez A; Sheng M; Good LB; Ma Q; Marin-Valencia I; Zhang X; Park JY; Hynan LS; Stavinoha P; Roe CR; Lu H
    JAMA Neurol; 2014 Oct; 71(10):1255-65. PubMed ID: 25110966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glut1 deficiency (G1D): epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype.
    Marin-Valencia I; Good LB; Ma Q; Duarte J; Bottiglieri T; Sinton CM; Heilig CW; Pascual JM
    Neurobiol Dis; 2012 Oct; 48(1):92-101. PubMed ID: 22683290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of triheptanoin with the ketogenic diet in Glucose transporter type 1 deficiency (G1D).
    Avila A; Málaga I; Sirsi D; Kayani S; Primeaux S; Kathote GA; Jakkamsetti V; Kallem RR; Putnam WC; Park JY; Shinnar S; Pascual JM
    Sci Rep; 2023 Jun; 13(1):8951. PubMed ID: 37268656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndrome.
    Striano P; Auvin S; Collins A; Horvath R; Scheffer IE; Tzadok M; Miller I; Kay Koenig M; Lacy A; Davis R; Garcia-Cazorla A; Saneto RP; Brandabur M; Blair S; Koutsoukos T; De Vivo D
    Epilepsia; 2022 Jul; 63(7):1748-1760. PubMed ID: 35441706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum dose, safety, tolerability and ketonemia after triheptanoin in glucose transporter type 1 deficiency (G1D).
    Málaga I; Avila A; Primeaux S; Kallem RR; Roe CR; Putnam WC; Park JY; Shinnar S; Ahn C; Pascual JM
    Sci Rep; 2023 Mar; 13(1):3465. PubMed ID: 36859467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic modulation of synaptic failure and thalamocortical hypersynchronization with preserved consciousness in Glut1 deficiency.
    Rajasekaran K; Ma Q; Good LB; Kathote G; Jakkamsetti V; Liu P; Avila A; Primeaux S; Enciso Alva J; Markussen KH; Marin-Valencia I; Sirsi D; Hacker PMS; Gentry MS; Su J; Lu H; Pascual JM
    Sci Transl Med; 2022 Oct; 14(665):eabn2956. PubMed ID: 36197967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose Transporter Type I Deficiency (G1D) at 25 (1990-2015): Presumptions, Facts, and the Lives of Persons With This Rare Disease.
    Pascual JM; Ronen GM
    Pediatr Neurol; 2015 Nov; 53(5):379-93. PubMed ID: 26341673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.
    Marin-Valencia I; Good LB; Ma Q; Malloy CR; Pascual JM
    J Cereb Blood Flow Metab; 2013 Feb; 33(2):175-82. PubMed ID: 23072752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Aspects of Glucose Transporter Type 1 Deficiency: Information From a Global Registry.
    Hao J; Kelly DI; Su J; Pascual JM
    JAMA Neurol; 2017 Jun; 74(6):727-732. PubMed ID: 28437535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect.
    Hainque E; Gras D; Meneret A; Atencio M; Luton MP; Barbier M; Doulazmi M; Habarou F; Ottolenghi C; Roze E; Mochel F
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1291-1293. PubMed ID: 30948626
    [No Abstract]   [Full Text] [Related]  

  • 11. Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer's Disease.
    Yuan X; Wang L; Tandon N; Sun H; Tian J; Du H; Pascual JM; Guo L
    J Alzheimers Dis; 2020; 78(1):425-437. PubMed ID: 33016909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variety of symptoms of GLUT1 deficiency syndrome in three-generation family.
    Winczewska-Wiktor A; Hoffman-Zacharska D; Starczewska M; Kaczmarek I; Badura-Stronka M; Steinborn B
    Epilepsy Behav; 2020 May; 106():107036. PubMed ID: 32247176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition from ketogenic diet to triheptanoin in patients with GLUT1 deficiency syndrome.
    Hainque E; Meneret A; Gras D; Atencio M; Luton MP; Barbier M; De Saint Martin A; Billette de Villemeur T; Ottolenghi C; Roze E; Mochel F
    J Neurol Neurosurg Psychiatry; 2020 Apr; 91(4):444-445. PubMed ID: 31694879
    [No Abstract]   [Full Text] [Related]  

  • 14. Triheptanoin for the treatment of brain energy deficit: A 14-year experience.
    Mochel F
    J Neurosci Res; 2017 Nov; 95(11):2236-2243. PubMed ID: 28688166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects.
    Wang D; Pascual JM; Yang H; Engelstad K; Jhung S; Sun RP; De Vivo DC
    Ann Neurol; 2005 Jan; 57(1):111-8. PubMed ID: 15622525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cells as glucose carriers to the human brain: Modulation of cerebral activity by erythrocyte exchange transfusion in Glut1 deficiency (G1D).
    Wang RC; Lee EE; De Simone N; Kathote G; Primeaux S; Avila A; Yu DM; Johnson M; Good LB; Jakkamsetti V; Sarode R; Holland AA; Pascual JM
    J Cereb Blood Flow Metab; 2023 Mar; 43(3):357-368. PubMed ID: 36523131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a LC-MS/MS method for quantitation of 3-hydroxypentanoic acid and 3-oxopentanoic acid in human plasma and its application to a clinical study of glucose transporter type I deficiency (G1D) syndrome.
    Kallem RR; Primeaux S; Avila A; Pascual JM; Putnam WC
    J Pharm Biomed Anal; 2021 Oct; 205():114335. PubMed ID: 34482182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous Ketone Supplements Improved Motor Performance in Preclinical Rodent Models.
    Ari C; Murdun C; Goldhagen C; Koutnik AP; Bharwani SR; Diamond DM; Kindy M; D'Agostino DP; Kovacs Z
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32824223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLUT-1 deficiency without epilepsy--an exceptional case.
    Overweg-Plandsoen WC; Groener JE; Wang D; Onkenhout W; Brouwer OF; Bakker HD; De Vivo DC
    J Inherit Metab Dis; 2003; 26(6):559-63. PubMed ID: 14605501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLUT1 deficiency syndrome in clinical practice.
    Klepper J
    Epilepsy Res; 2012 Jul; 100(3):272-7. PubMed ID: 21382692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.